Activation of the GPx2 promoter by β-catenin [91], which is the key mediator in the Wnt pathway and constitutively active in most of intestinal cancers, can again be interpreted controversially, either as an attempt to counteract carcinogenesis or to sustain cancer cell growth. Here, GPX2 is linked to cancer.